Beta-Blockers in Patients With COPD and CVD - American College of Cardiology
Quick TakesAmong patients with both chronic obstructive pulmonary (COPD) and cardiovascular disease, beta-blockers were associated with reduced all-cause mortality (hazard ratio, 0.70).Cardioselective beta-blockers were associated with reduced risk of COPD exacerbation (hazard ratio, 0.72), while noncardioselective beta-blockers had no significant impact in this regard. Study Questions: What is the effect of beta-blockers on respiratory function and survival in patients with chronic obstructive pulmonary... Читать дальше...